[PHARMA] QoQ Quarter Result on 30-Jun-2013 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
16-Aug-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
30-Jun-2013 [#2]
Profit Trend
QoQ- -76.32%
YoY- -62.67%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
Revenue 468,672 567,860 440,807 437,633 500,339 482,404 426,460 6.50%
PBT 38,159 33,007 13,461 9,605 36,924 4,248 28,493 21.52%
Tax -11,513 -11,740 -9,291 -3,434 -11,771 -11,716 -2,957 147.69%
NP 26,646 21,267 4,170 6,171 25,153 -7,468 25,536 2.87%
-
NP to SH 26,217 20,813 3,751 5,865 24,771 -7,934 25,247 2.54%
-
Tax Rate 30.17% 35.57% 69.02% 35.75% 31.88% 275.80% 10.38% -
Total Cost 442,026 546,593 436,637 431,462 475,186 489,872 400,924 6.72%
-
Net Worth 515,022 486,672 473,402 480,568 484,829 472,037 496,469 2.47%
Dividend
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
Div 10,352 16,049 7,760 8,810 8,825 11,771 11,764 -8.17%
Div Payout % 39.49% 77.11% 206.90% 150.22% 35.63% 0.00% 46.60% -
Equity
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
Net Worth 515,022 486,672 473,402 480,568 484,829 472,037 496,469 2.47%
NOSH 258,805 258,868 258,689 258,370 117,676 117,715 117,646 69.22%
Ratio Analysis
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
NP Margin 5.69% 3.75% 0.95% 1.41% 5.03% -1.55% 5.99% -
ROE 5.09% 4.28% 0.79% 1.22% 5.11% -1.68% 5.09% -
Per Share
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
RPS 181.09 219.36 170.40 169.38 425.18 409.81 362.49 -37.06%
EPS 10.13 8.04 1.45 2.27 21.05 -6.74 21.46 -39.40%
DPS 4.00 6.20 3.00 3.41 7.50 10.00 10.00 -45.74%
NAPS 1.99 1.88 1.83 1.86 4.12 4.01 4.22 -39.44%
Adjusted Per Share Value based on latest NOSH - 258,370
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
RPS 32.52 39.40 30.58 30.36 34.72 33.47 29.59 6.50%
EPS 1.82 1.44 0.26 0.41 1.72 -0.55 1.75 2.65%
DPS 0.72 1.11 0.54 0.61 0.61 0.82 0.82 -8.31%
NAPS 0.3573 0.3377 0.3285 0.3334 0.3364 0.3275 0.3445 2.46%
Price Multiplier on Financial Quarter End Date
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
Date 31/03/14 31/12/13 30/09/13 28/06/13 29/03/13 31/12/12 28/09/12 -
Price 4.46 4.45 4.82 4.49 8.26 8.10 7.55 -
P/RPS 2.46 2.03 2.83 2.65 1.94 1.98 2.08 11.84%
P/EPS 44.03 55.35 332.41 197.80 39.24 -120.18 35.18 16.15%
EY 2.27 1.81 0.30 0.51 2.55 -0.83 2.84 -13.88%
DY 0.90 1.39 0.62 0.76 0.91 1.23 1.32 -22.55%
P/NAPS 2.24 2.37 2.63 2.41 2.00 2.02 1.79 16.14%
Price Multiplier on Announcement Date
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
Date 14/05/14 24/02/14 19/11/13 16/08/13 15/05/13 18/02/13 06/11/12 -
Price 4.70 4.29 4.72 4.66 9.26 7.80 8.25 -
P/RPS 2.60 1.96 2.77 2.75 2.18 1.90 2.28 9.15%
P/EPS 46.40 53.36 325.52 205.29 43.99 -115.73 38.44 13.38%
EY 2.16 1.87 0.31 0.49 2.27 -0.86 2.60 -11.63%
DY 0.85 1.45 0.64 0.73 0.81 1.28 1.21 -20.99%
P/NAPS 2.36 2.28 2.58 2.51 2.25 1.95 1.95 13.58%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment